EUVIMEDEUVIMED entdecken
Crossref

Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project

Diana Dubrall, Maren Paulmann, Wilma Fischer-Barth, Jens Bate, Matthias Schmid, Bernhardt Sachs, Maja Mockenhaupt

Dermatology · 19.06.2026 · 1-19

DOI: 10.1159/000552416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, online erschienen am 19.06.2026. Verfasst von Diana Dubrall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, University of Bonn, Bonn, Germany, diana.dubrall@bfarm.de. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell-mediated severe cutaneous adverse reaction (SCAR) to drugs. Due to its rarity, there are currently only a few studies which include a larger number of cases. We sought to analyze a larger number of DRESS cases to increase knowledge of clinical symptoms, causative agents, and potentially associated factors.

Methods

This is a non-interventional, retrospective, pharmacoepidemiological study analyzing descriptively DRESS reports in the EudraVigilance ADR database (EV) and DRESS cases in the registry of dZh/RegiSCAR. The two databases were analyzed separately, and the results were compared thereafter to identify both similarities and differences.

Results

48 cases from EV and 84 RegiSCAR cases were included for the in-depth analysis. The liver was the most frequently involved inner organ. Most of the reactions occurred within 6 weeks after initiating the suspected inducing agent. The percentage of cases with fatal outcome was similar in both datasets (EV: 4.2%, RegiSCAR: 3.6%). Antiseizure drugs – especially carbamazepine – were most frequently involved in both datasets. In 4 reports from EV and 5 cases from RegiSCAR, sulfasalazine was identified as causative agent. Remarkably, all patients with sulfasalazine-induced DRESS were females with arthritic disease who were clearly younger compared to patients of the whole dataset.

Conclusion

Our study confirms results obtained from other studies regarding the frequent involvement of the liver, the time to onset, and DRESS-inducing drugs. Further studies are needed to investigate whether younger female with arthritic disease may carry a higher risk to develop DRESS or whether other factors might be responsible for this observation.

Schlagwörter

Stichwörter der Autor:innen

Adverse drug reactionDrug hypersensitivity syndromeDrug reaction with eosinophilia and systemic symptomsDrug-induced hypersensitivity syndromeEudraVigilanceRegiSCARSpontaneous reports

Autor:innen und Institutionen

  • Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, University of Bonn, Bonn, Germany, diana.dubrall@bfarm.de.
  • Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany, diana.dubrall@bfarm.de.
  • Dokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology, Medical Center - University of Freiburg, Freiburg, Germany.
  • Pharmacovigilance Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
  • Clinical Trials Section, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
  • Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, University of Bonn, Bonn, Germany.

Zitieren

APA

Dubrall, D., Paulmann, M., Fischer-Barth, W., Bate, J., Schmid, M., Sachs, B., & Mockenhaupt, M. (2026). Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project. Dermatology, 1-19. https://doi.org/10.1159/000552416

Vancouver

Dubrall D, Paulmann M, Fischer-Barth W, Bate J, Schmid M, Sachs B, et al. Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project. Dermatology. 2026:1-19. doi:10.1159/000552416

BibTeX
@article{Dubrall2026,
  author = {Dubrall, Diana and Paulmann, Maren and Fischer-Barth, Wilma and Bate, Jens and Schmid, Matthias and Sachs, Bernhardt and Mockenhaupt, Maja},
  title = {Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project},
  journal = {Dermatology},
  year = {2026},
  pages = {1--19},
  doi = {10.1159/000552416}
}
Kostenlos starten →